ArticleCancer gene therapy2011

Therapeutic effectiveness of intratumorally delivered dendritic cells engineered to express the pro-inflammatory cytokine, interleukin (IL)-32.

Y Qu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.